Liminatus Pharma Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Liminatus Pharma Inc (LIMN) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
API endpoints for this dataset
Liminatus Pharma Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Liminatus Pharma Inc | - | - | - | Yes |
| High-Confidence Competitors (8) | ||||
| Similar-Size Competitors (10) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
LIMN Stock Performance relative to its Competitors
LIMN Stock Performance relative to High-Confidence Competitors
LIMN Stock Performance relative to Similar-Size Competitors
Liminatus Pharma Inc's Comment on Competition and Industry Peers
Liminatus Pharma Inc's Competitors Named by the Company
Competitive relationships identified from Liminatus Pharma Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Forty Seven | Company report | 85% |
| Pfizer | Company report | 85% |
| AstraZeneca | Company report | 85% |
| Merck | Company report | 85% |
| Genentech | Company report | 85% |
| BMS | Company report | 85% |
| Novartis | Company report | 85% |
| Amgen | Company report | 85% |
| Gilead Sciences | Company report | 85% |
Company report basis, confidence, active dates and source counts for Liminatus Pharma Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.